327 related articles for article (PubMed ID: 9879409)
1. A comparative study of the clinical efficacy of immunotherapy and conventional pharmacological treatment for patients with perennial allergic rhinitis.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Yamada K; Sakamoto H; Nasako Y; Hayashi M; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():102-12. PubMed ID: 9879409
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S
Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S; Ozcora E; Dirican A
ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):144-50. PubMed ID: 18391573
[TBL] [Abstract][Full Text] [Related]
4. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
[TBL] [Abstract][Full Text] [Related]
5. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
6. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus.
Tsai JJ; Liao EC; Tsai FH; Hsieh CC; Lee MF
J Asthma; 2009 Mar; 46(2):165-70. PubMed ID: 19253124
[TBL] [Abstract][Full Text] [Related]
7. Short-term efficacy of nasal immunotherapy.
Palma-Carlos AG; Santos AS; Pregal A
Allerg Immunol (Paris); 1998 Jan; 30(1):14-7. PubMed ID: 9503098
[TBL] [Abstract][Full Text] [Related]
8. Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial allergic rhinitis.
Washio Y; Ohashi Y; Tanaka A; Kakinoki Y; Sugiura Y; Sakamoto H; Yamada K; Matsuda M; Uekawa M; Okamoto H; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():126-32. PubMed ID: 9879412
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of sublingual immunotherapy with dermatophagoides farinae drops in patients with allergic rhinitis].
Li TY; Chen DH; Lin ZB; Xu R
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Oct; 46(10):859-62. PubMed ID: 22321427
[TBL] [Abstract][Full Text] [Related]
10. Low-dose local nasal immunotherapy in children with perennial allergic rhinitis due to Dermatophagoides.
Marcucci F; Sensi LG; Caffarelli C; Cavagni G; Bernardini R; Tiri A; Riva G; Novembre E
Allergy; 2002 Jan; 57(1):23-8. PubMed ID: 11991284
[TBL] [Abstract][Full Text] [Related]
11. [Monitoring the efficacy of immunotherapy by symptom scores and the skin prick test in patients with allergic rhinitis].
Akbaş Y; Saatçi MR
Kulak Burun Bogaz Ihtis Derg; 2003 Jun; 10(6):221-5. PubMed ID: 13679688
[TBL] [Abstract][Full Text] [Related]
12. [Rush immunotherapy of perennial allergic rhinitis].
Ito K
Arerugi; 1989 Nov; 38(11):1246-54. PubMed ID: 2627159
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy in allergic rhinitis.
Palma-Carlos AG; Spinola-Santos A; Ferreira MB; Santos MC; Palma-Carlos ML
Allerg Immunol (Paris); 2001 Oct; 33(8):323-6. PubMed ID: 11763723
[TBL] [Abstract][Full Text] [Related]
14. Effect of specific immunotherapy versus loratadine on serum adhesion molecules.
Ferreira MB; Santos MC; Pregal AL; Alonso E; Santos AS; Palma-Carlos ML; Palma-Carlos AG
Allerg Immunol (Paris); 2001 Oct; 33(8):319-22. PubMed ID: 11763722
[TBL] [Abstract][Full Text] [Related]
15. [Clinical efficacy and safety of sublingual immunotherapy using standardized Dermatophagoides farinae extract for children with combined allergic rhinitis and asthma syndrome].
Wen CJ; Zhu MF; Ren WM; Liu XY; Qian H
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 May; 46(5):393-6. PubMed ID: 21781561
[TBL] [Abstract][Full Text] [Related]
16. [The results of specific immunotherapy for house dust mites in patients with allergic rhinitis].
Sahin E; Taş E; Dağtekin Ergür EN; Cuhali BD; Gürsel AO
Kulak Burun Bogaz Ihtis Derg; 2008; 18(2):79-84. PubMed ID: 18628641
[TBL] [Abstract][Full Text] [Related]
17. Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.
Marcucci F; Sensi L; Di Cara G; Salvatori S; Bernini M; Pecora S; Burastero SE
Pediatr Allergy Immunol; 2005 Sep; 16(6):519-26. PubMed ID: 16176400
[TBL] [Abstract][Full Text] [Related]
18. A case control study of dermatophagoides immunotherapy in children below 5 years of age.
Di Bernardino C; Di Bernardino F; Colombo R; Angrisano A
Allerg Immunol (Paris); 2002 Feb; 34(2):56-9. PubMed ID: 11933755
[TBL] [Abstract][Full Text] [Related]
19. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
Saraçlar Y; Sekerel BE; Kalayci O; Adalioğlu G; Tuncer A
J Investig Allergol Clin Immunol; 1998; 8(2):98-104. PubMed ID: 9615303
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Ohno Y; Yamada K; Nasako Y
Acta Otolaryngol Suppl; 1998; 538():113-7. PubMed ID: 9879410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]